Saund Saran
Insider CIK 1834417 · OTLC Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2026-07-10 | 2026-07-14 | 1,500 | — | $0 | 1,500 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2021-09-03 | 2021-09-08 | 675,000 | — | $0 | 675,000 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2021-07-08 | 2021-07-16 | 216,279 | — | $0 | 216,279 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award | 2021-07-08 | 2021-07-16 | 102,519 | — | $0 | 16,457,480 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion deriv | 2021-03-31 | 2021-07-16 | 16,355 | — | $0 | 0 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion | 2021-03-31 | 2021-07-16 | 16,354,961 | — | $0 | 16,354,961 | SEC↗ |